This is nothing but a political stunt motivated by the same shameless greed that we’re used to seeing from drug corporations that have made decades of inflated profits at the expense of patients’ health and taxpayers’ hard-earned money.
Statement from Margarida Jorge, head of Lower Drug Prices Now – the leading campaign fighting to lower prescription drug prices – on the Senate HELP Committee hearing on Insulin:
Certainly, these multi-million-dollar CEOs will spend their time in front of the committee patting themselves on the back for bowing to public pressure and lowering the cost of insulin.
Let’s be clear, the tens of millions of Americans who can not afford their prescription medication should not have to depend on the good will of reedy corporations who have repeatedly shown they care about profits more than people to bring them relief from skyrocketing prescription costs.
The President’s executive order to rein in drug corporations’ monopoly control over prices comes in stark contrast to Senate Republicans’ introduction of legislation to repeal lower drug drug costs in the Inflation Reduction Act even before the law is implemented.
Today is a huge defeat for Big Pharma and a huge victory for patients who have long endured the drug corporations’ relentless price-gouging. Pharma’s monopoly power to set and raise prices as high as they want has put affordable medicine out of the reach of millions of people for years and caused untold harm.
We are now one, very important, step closer to a historic victory for consumers and a historic defeat for Big Pharma’s monopoly control over prescription drug prices.
Statement from Margarida Jorge, head of Lower Drug Prices Now – the leading campaign fighting to lower prescription drug prices – in response to House passage a bill to cap the cost of insulin:
This legislation is a positive step, but it falls far short of the kind of real reform that millions of Americans need for all kinds of health conditions.